Found 6 matching trials
A Study to Evaluate the Safety, Tolerability and Plasma Concentration Profiles of MK0633 in Asthmatic Children Aged 12 to Less Than 16 Years (0633-019) PHASE1 To evaluate the safety, tolerability and pharmacokinetics (PK) of MK0633 in...
Show More Location
Multiple Locations
Learn More & Join Trial
MK0633 Single Dose Study in Japanese Asthmatic Children Aged 12 to Less Than 16 Years (0633-028) PHASE1 This study evaluates the safety, tolerability and pharmacokinetics (PK) of ...
Show More Location
Multiple Locations
Learn More & Join Trial
Plasma Levels of MK0633 in Children Ages 6-12 (0633-023) PHASE1 To evaluate the safety, tolerability and plasma levels of single oral doses...
Show More Location
Multiple Locations
Learn More & Join Trial
The Effect of MK0633 in Patients With Chronic Asthma (0633-007) PHASE2 A clinical study to evaluate the efficacy and safety of MK0633 in adult pat...
Show More Location
Multiple Locations
Learn More & Join Trial
The Effect of MK 0633 in Patients With Atherosclerosis (0633-008)(COMPLETED) PHASE2 A study to test the effects of study drug (MK 0633) on patients with Athero...
Show More Location
Multiple Locations
Learn More & Join Trial
A Research Study of MK0633 in Patients With Chronic Obstructive Pulmonary Disease (COPD)(0633-009)(COMPLETED) PHASE2 A clinical study to evaluate the efficacy and safety of MK0633 in patients ...
Show More Location
Multiple Locations
Learn More & Join Trial